Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.17 CAD
Change Today 0.00 / 0.00%
Volume 37.4K
SBM On Other Exchanges
As of 2:23 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

sirona biochem corp (SBM) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/7/15 - C$0.20
52 Week Low
10/16/14 - C$0.11
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SIRONA BIOCHEM CORP (SBM)

Related News

No related news articles were found.

sirona biochem corp (SBM) Related Businessweek News

No Related Businessweek News Found

sirona biochem corp (SBM) Details

Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada. The company develops programs in three areas, including diabetes and cancer therapeutics; anti-aging and depigmenting agent in cosmeceuticals; biological ingredients, such as inducers and adjuvants for biological development. It develops a sodium glucose co-transporter inhibitor for the treatment of Type 2 diabetes; and a cancer vaccine antigen. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Founded in 2006

sirona biochem corp (SBM) Top Compensated Officers

Founder, Chairman of the Board, Chief Executi...
Total Annual Compensation: C$105.0K
Chief Financial Officer, Director and Member ...
Total Annual Compensation: C$105.0K
Chief Scientific Officer and Director
Total Annual Compensation: C$167.4K
Compensation as of Fiscal Year 2014.

sirona biochem corp (SBM) Key Developments

Sirona Biochem Corp. Announces Board Changes

Sirona Biochem Corp. announced the appointment of Mr. Casper Bych to its Board of Directors. Mr. Bych has more than 20 years’ experience in management and in the legal and financial industry in Europe, South and North America. Casper is the President and CEO of Mountainview Capital Corporation. The company also announced that Mr. Nigel Terrett has resigned as a director.

Sirona Biochem Corp., Annual General Meeting, Aug 21, 2015

Sirona Biochem Corp., Annual General Meeting, Aug 21, 2015., at 10:00 Pacific Standard Time. Location: Suite 605,. Agenda: To receive and consider the audited financial statements of the company for the financial year ended October 31, 2014, together with the auditors' report thereon; to fix the number of directors for the ensuing year at seven; to elect directors of the company for the ensuing year; to appoint the auditors of the company for the ensuing year and to authorize the directors to fix the auditors' remuneration; to consider and if thought fit, pass an ordinary resolution adopting the company's 2015 stock option plan and to transact such other business that may properly come before the Meeting and any adjournment thereof.

Sirona Reports Revenue Results for the Second Quarter of 2015

Sirona reported revenue results for the second quarter of 2015. For the quarter, revenue was $257.3 million representing an increase of 2% compared to $282.7 million in second quarter of 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBM:CN C$0.17 CAD 0.00

SBM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SBM.
View Industry Companies

Industry Analysis


Industry Average

Valuation SBM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales NM Not Meaningful
Price/Book 13.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIRONA BIOCHEM CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at